<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Kiilerich | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/turkeycase7/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/turkeycase7/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Kiilerich.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">3ed194d181f66180bb8370c8ae08f44f</guid>
				<title>Kiilerich posted an update: Mechanistically, STS reduced activation of ERK1/2 and NF-κB [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41712/</link>
				<pubDate>Sat, 08 Feb 2025 10:26:36 -0800</pubDate>

									<content:encoded><![CDATA[<p>Mechanistically, STS reduced activation of ERK1/2 and NF-κB in lungs of CS-exposed mice and CSE-treated 16HBE cells challenged with LPS. Taken together, STS protects against acute exacerbation of CS-induced lung injury, which provides a promising and potential therapeutic avenue to halt acute exacerbation of COPD. Dendritic cells (DCs) can&hellip;<span class="activity-read-more" id="activity-read-more-41712"><a href="http://www.nationalboardinstitute.com/activity/p/41712/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d104cac61ed6f5b20570c04ab4b8ef26</guid>
				<title>Kiilerich posted an update: The databases utilized will include MEDLINE via PubMed, [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40274/</link>
				<pubDate>Thu, 06 Feb 2025 15:13:11 -0800</pubDate>

									<content:encoded><![CDATA[<p>The databases utilized will include MEDLINE via PubMed, EMBASE and Cochrane Central Register of Controlled Trials and Grey Literature. SCOPING REVIEW REGISTRATION Open Science Framework https//osf.io/vphwm/.As the biology of mesenchymal stromal cells (MSCs) in patients with non-malignant hematological diseases (NMHD) is poorly understood, in the&hellip;<span class="activity-read-more" id="activity-read-more-40274"><a href="http://www.nationalboardinstitute.com/activity/p/40274/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e25aae76f9c07e866e94275573a52fa5</guid>
				<title>Kiilerich posted an update: Together, we provided the first evidence that resveratrol [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38302/</link>
				<pubDate>Tue, 04 Feb 2025 10:47:51 -0800</pubDate>

									<content:encoded><![CDATA[<p>Together, we provided the first evidence that resveratrol promotes muscle fiber type conversion from fast-twitch to slow-twitch via miR-22-3p and AMPK/SIRT1/PGC-1α pathway in C2C12 myotubes. Articular cartilage repair has been a long-standing challenge in orthopaedic medicine due to the limited self-regenerative capability of cartilage tissue.&hellip;<span class="activity-read-more" id="activity-read-more-38302"><a href="http://www.nationalboardinstitute.com/activity/p/38302/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c32d851bf7862cbe92268da9438028e3</guid>
				<title>Kiilerich posted an update: 7 ± 1.4 mm generating a mean offsetwidth ratio of 0.38 ± 0 [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37430/</link>
				<pubDate>Mon, 03 Feb 2025 10:32:08 -0800</pubDate>

									<content:encoded><![CDATA[<p>7 ± 1.4 mm generating a mean offsetwidth ratio of 0.38 ± 0.09. No chiasm had an offset of zero. The mean incident angle of optic nerves was 56 ± 7°, and for optic tracts, it was 51 ± 7°. CONCLUSIONS The human optic chiasm is &#8220;H&#8221; shaped, not &#8220;X&#8221; shaped. The findings are consistent with nasal fibers decussating an average of 2.4 mm lateral to the m&hellip;<span class="activity-read-more" id="activity-read-more-37430"><a href="http://www.nationalboardinstitute.com/activity/p/37430/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d461fc44b1b8ec3e3b38d484e972a5ba</guid>
				<title>Kiilerich posted an update: We report the conversion of amides to carboxylic acids using [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35625/</link>
				<pubDate>Sat, 01 Feb 2025 10:22:47 -0800</pubDate>

									<content:encoded><![CDATA[<p>We report the conversion of amides to carboxylic acids using nonprecious metal catalysis. The methodology strategically employs a nickel-catalyzed esterification using 2-(trimethylsilyl)ethanol, followed by a fluoride-mediated deprotection in a single-pot operation. This approach circumvents catalyst poisoning observed in attempts to directly&hellip;<span class="activity-read-more" id="activity-read-more-35625"><a href="http://www.nationalboardinstitute.com/activity/p/35625/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1e48defd5cff858db4d6ffbe0295d518</guid>
				<title>Kiilerich posted an update: Rational drug design and in vitro pharmacology profiling [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/32049/</link>
				<pubDate>Tue, 28 Jan 2025 17:50:21 -0800</pubDate>

									<content:encoded><![CDATA[<p>Rational drug design and in vitro pharmacology profiling constitute the gold standard in drug development pipelines. Problems arise, however, because this process is often difficult due to limited information regarding the complete identification of a molecule&#8217;s biological activities. The increasing affordability of genome-wide next-generation&hellip;<span class="activity-read-more" id="activity-read-more-32049"><a href="http://www.nationalboardinstitute.com/activity/p/32049/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">25f8da51d44751f527c412333be36a4f</guid>
				<title>Kiilerich became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/32017/</link>
				<pubDate>Tue, 28 Jan 2025 17:47:35 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>